Fine and gross motor skills differ between healthy-weight and obese children

Ilse Gentier1, Eva D'Hondt, Sarah Shultz

  • 1Department of Movement and Sports Sciences, Ghent University, Watersportlaan 2, 9000 Ghent, Belgium; Research Foundation - Flanders (FWO), Brussels, Belgium.

Insights

Obese children show deficits in both gross and fine motor skills compared to healthy-weight peers. These motor skill challenges in obese children extend beyond gross movements, impacting fine motor abilities as well.

Area of Science:

  • Pediatric obesity
  • Motor development
  • Child psychology

Background:

  • Obesity in children is linked to gross motor skill deficits.
  • Fine motor skill research in obese children is limited.
  • Understanding motor skill differences is crucial for intervention.

Purpose of the Study:

  • To investigate weight-related differences in gross and fine motor skills in obese children.
  • To compare motor skill performance between obese and healthy-weight children.
  • To identify specific areas of motor impairment in childhood obesity.

Main Methods:

  • Study included 34 obese and 34 healthy-weight children (aged 7-13).
  • Motor skills assessed using the Bruininks-Oseretsky Test of Motor Proficiency, second edition (BOT-2).
  • Statistical analyses included t-tests, MANOVA, and chi-squared tests.

Main Results:

  • Obese children performed worse on all gross motor skill subtests.
  • Obese children showed deficits in fine motor precision and manual dexterity.
  • No significant differences were found in fine motor integration tasks between groups.

Conclusions:

  • Childhood obesity negatively impacts both gross and fine motor skills.
  • Motor competence issues in obese children are not confined to gross motor abilities.
  • Further research is needed to explore sensory processing and underlying mechanisms.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...